The Company is pursuing two parallel paths to growth: we are creating innovative proprietary solutions that disrupt incumbent players and at the same time we are acquiring synergistic assets that increase speed-to-market and deliver profits. Biosign continues to execute both these strategies by improving our patent-pending Pulsewave® technology while simultaneously integrating QCARE & ClinicServer with additional assets into a unique and compelling platform.

Under this strategy Biosign is participating in the Qualcomm Tricorder XPRIZE competition, a $10 million innovation contest to develop a Star Trek-like software system to record all 5 vital signs and independently diagnose 15 separate diseases. A 2012 study by Parks Associates ("Digitally Fit: Healthy Living and Connected Devices") predicts that more than 32 million US consumers will actively track their health & fitness online by 2016, up from about 15 million in 2011 (~100% growth). Revenue from online / mobile wellness service adoption will increase from $337 million in 2011 to more than $2.4 billion by 2016 (~700% growth), according to the study.

From the press release, "Biosign positions itself for growth: Strengthens the Board, secures debt financing & looks to acquire additional software assets."